• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Background Enterococcal bacteraemia (EB) is common, particularly in the nosocomial
setting, and its management poses a challenge for clinicians and microbiologists. Objectives …

Background: Streptococci frequently cause infective endocarditis (IE), yet the prevalence of
IE in patients with bloodstream infections (BSIs) caused by different streptococcal species is …

Background Enterococcus faecalis infective endocarditis (EFIE) is characterized by a higher
frequency of relapses than other infective endocarditis. The role of the treatment on its …

Background Infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is
associated with high mortality and surgery is rarely performed. Thus, to inform on preventive …

Aims Little is known about the mortality for patients with infective endocarditis (IE) on a
nationwide scale, and previous studies have been conducted in selected cohorts from …

Background Infective endocarditis (IE) remains a life-threatening disease, yet substantial
variation in reported incidences of the disease exist. We aimed to conduct a contemporary …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The modified Duke criteria requires that Enterococcus faecalis bacteremia must be both
community-acquired and without known focus in order to be considered a microbiological …

Background Patients with bacteraemia caused by gram-positive bacteria are at risk for
infective endocarditis (IE). Because IE needs long antibiotic treatment and sometimes heart …